Month: January 2020

(Originally posted January 21, 2020 and March 1, 2019) BREAKING NEWS: The FDA has approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease. Wiley Chambers, M.D., deputy director…